TheraCryf PLC is a clinical-stage therapeutics company developing innovative medicines for oncology and behavioral brain disorders, including substance use disorders, anxiety, and glioblastoma.

Theracryf Logo

Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.

About Theracryf

TheraCryf PLC is a clinical-stage therapeutics company focused on developing innovative medicines for oncology and behavioral brain disorders, including substance use disorders, anxiety, fatigue, narcolepsy, and glioblastoma. Its pipeline features an orexin-1 antagonist for addictive behaviors and anxiety, a dopamine transporter inhibitor for fatigue and narcolepsy, and a sulforaphane-based therapy for glioblastoma. TheraCryf aims to demonstrate proof of concept for its proprietary drug candidates and partner with larger pharmaceutical companies for further development and commercialization.

Year founded

2014

Number of employees

0-100

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Add TheraCryf logo and brand data to your app or website

Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.

<img src="https://img.logokit.com/theracryf.com" />

Report inaccurate data

Request an update to help us keep the brand up-to-date.

One API,
Millions of Logos

Get Started Contact Us
One API, Millions of Logos